OptimizeRx Price to Free Cash Flow Ratio 2010-2022 | OPRX

Historical price to free cash flow ratio values for OptimizeRx (OPRX) since 2010. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
OptimizeRx Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2022-05-20 26.12 186.57
2022-03-31 37.71 $0.14 269.36
2021-12-31 62.11 $0.01 4196.62
2021-09-30 85.55 $-0.07 0.00
2021-06-30 61.90 $-0.09 0.00
2021-03-31 48.75 $-0.07 0.00
2020-12-31 31.16 $-0.43 0.00
2020-09-30 20.85 $-0.37 0.00
2020-06-30 13.03 $-0.43 0.00
2020-03-31 9.06 $-0.45 0.00
2019-12-31 10.27 $-0.13 0.00
2019-09-30 14.48 $0.06 238.16
2019-06-30 16.20 $0.22 72.94
2019-03-31 12.72 $0.13 97.17
Sector Industry Market Cap Revenue
Computer and Technology Computer Software $0.474B $0.061B
OptimizeRx Corporation provides consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products. It offers pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. The Company offers marketing and advertising solutions by connecting patients, physicians, and pharmaceutical manufacturers through its consumer Websites. OptimizeRx Corporation is based in Rochester, Michigan.
Stock Name Country Market Cap PE Ratio
Oracle (ORCL) United States $183.116B 15.60
Salesforce (CRM) United States $158.112B 60.70
VMware (VMW) United States $40.299B 18.95
BlackBerry (BB) Canada $3.395B 0.00
PROS Holdings (PRO) United States $1.240B 0.00
SAP SE (SAP) Germany $0.000B 18.49